Covid–19 coronavirus: global merger review (updated 30 November 2020)
30 ноября 2020
Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid-19 coronavirus.
While critical transactions are likely to be reviewed, as far as possible, in accordance with normal practice, many cases may face changes in approach and practice (eg extensions of timelines in certain circumstances). See our overview for an indication of the different approaches being taken by authorities around the world.